Further details of the plans in force are provided in the table below:
TABLE 9, BASED ON THE AFEP-MEDEF CODE TEMPLATE AND AMF RECOMMENDATION 2021-02
| not-included | 2020 PLAN | 2022 PLAN | 2022-2 PLAN | 2023 PLAN | 2023-2 PLAN | 2024 PLAN | 2024-2 PLAN |
|---|---|---|---|---|---|---|---|
| Date of Annual Shareholders Meeting | 01/22/2019 | 12/14/2021 | 12/14/2021 | 12/14/2021 | 12/14/2021 | 12/15/2023 | 12/15/2023 |
| Date of grant by the Board of Directors | 11/25/2020 | 02/01/2022 | 06/22/2022 | 01/31/2023 | 06/28/2023 | 02/23/2024 | 06/27/2024 |
| Total number of shares granted | 922,840 | 1,038,446 | 34,231 | 1,078,145 | 34,253 | 834,387 | 28,732 |
| Total number of beneficiaries | 2,145 | 2,181 | 25 | 2,332 | 41 | 2,116 | 27 |
| % of share capital | 0.63% | 0.70% | 0.02% | 0.75% | 0.02% | 0.57% | 0.02% |
| Performance conditions | |||||||
| Underlying operating profit | X | X | X | X | X | X | X |
| Revenue | X | X | X | X | X | X | X |
| TSR | X | X | X | X | X | X | X |
| Corporate responsibility | X | X | X | X | X | X | X |
| Plans | |||||||
| Vesting date | 16/1/2024(1) | 02/01/2025 | 06/22/2025 | 01/30/2026 | 06/27/2026 | 02/22/2027 | 06/26/2027 |
| Availability date | 01/17/2024 | 02/03/2025 | 06/23/2025 | 01/31/2026 | 06/28/2026 | 02/23/2027 | 06/28/2027 |
| Total number of shares granted | 922,840 | 1,038,446 | 34,231 | 1,078,145 | 34,253 | 834,387 | 28,732 |
| o/w to Corporate Officers | 28,000 | 47,119 | 46,706 | 0 | |||
| Sophie Bellon | not-included | not-included | not-included | 33,844 | not-included | 34,500 | not-included |
| Nathalie Bellon-Szabo | not-included | not-included | not-included | 13,275 | not-included | 12,206 | not-included |
| Denis Machuel | 28,000 | not-included | not-included | not-included | not-included | not-included | not-included |
| % of share capital | 0.02% | 0.00% | 0.00% | 0.02% | 0.00% | 0.03% | 0.00% |
| Aggregate number of shares canceled | 247,777 | 226,254 | 2,650 | 189,761 | 7,223 | 8,493 | 0 |
| Shares forfeited due to performance conditions not being met | 41,697 | 0 | 0 | 0 | 0 | 0 | 0 |
| Vested shares | 671,693 | N/A | N/A | N/A | N/A | N/A | N/A |
| Accelerated vesting for death and disability | 3,370 | 2,748 | 400 | 1,415 | 0 | 385 | 0 |
| TOTAL OF THE PLANS AT AUGUST 31, 2023 | 0 | 809,444 | 31,181 | 886,969 | 27,030 | 825,509 | 28,732 |
(1) Share vesting date brought forward from January 25, 2024, due to the proximity of this delivery date to that of the Pluxee spin-off, for operational management reasons.
(2) Adjustment to the number of outstanding performance shares (2022, 2022-2, 2023 and 2023-2 grants) in line with the impact of the Pluxee spin-off on Sodexo's share price (see explanations on the technical adjustment above the table).
As of August 31, 2024, a total of 2,608,865 restricted shares had been granted to Group Corporate Officers and managers and not yet vested (representing approximately 1.77% of the Company’s share capital as of the date of the Annual Shareholders Meeting of December 15, 2023), for a total amount of approximately 136 million euros (as measured in accordance with IFRS at the grant date).
| not-included | TOTAL NUMBER OF SHARES | PLAN DATE |
|---|---|---|
| Shares granted during Fiscal 2024 to the ten Group employees receiving the largest number of restricted shares (aggregate information) | 167,969 | 02/23/2024 06/27/2024 |
| Shares vested during Fiscal 2024 for the ten Group employees receiving the largest number of restricted shares (aggregate information) | 145,040 | 11/23/2020 |
